Patents Assigned to SAGABIO CO., LTD.
  • Patent number: 10808025
    Abstract: The present invention relates to a monoclonal antibody that inhibits immunosuppressive functions of pathogens, antigen-binding fragment thereof, and hybridomas producing such antibody. The monoclonal antibody or antigen-binding fragment thereof bind to a peptide consisting an amino acid sequence represented by MEKVGKDGVITVE (SEQ ID NO: 1). The present invention also discloses use of the invented monoclonal antibody or antigen-binding fragment thereof, and method of preparation for such hybridomas.
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: October 20, 2020
    Assignee: SAGABIO CO., LTD.
    Inventors: Kuang-Wen Liao, Yu-Ling Lin, Ting-Yan Jian
  • Patent number: 10577409
    Abstract: The present invention relates to a monoclonal antibody that inhibits immunosuppressive functions of pathogens, antigen-binding fragment thereof, and hybridomas producing such antibody. The monoclonal antibody or antigen-binding fragment thereof bind to a peptide consisting an amino acid sequence represented by MEKVGKDGVITVE (SEQ ID NO: 1). The present invention also discloses use of the invented monoclonal antibody or antigen-binding fragment thereof, and method of preparation for such hybridomas.
    Type: Grant
    Filed: May 26, 2016
    Date of Patent: March 3, 2020
    Assignee: SAGABIO CO., LTD.
    Inventors: Kuang-Wen Liao, Yu-Ling Lin, Ting-Yan Jian